This Week at FDA: Lawmakers ask about CURES 2.0, Califf wants more pragmatic clinical research

This Week at FDAThis Week at FDAAdvisory committeesBiologics/ biosimilars/ vaccinesGovernment/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)